A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001474-27

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective will be to determine the efficacy of repeated topical applications of Tazarotene together with Baceca or placebo in patients with basal cell carcinomas (BCC).


Critère d'inclusion

  • skin cancer of the type of Basal Cell Carcinoma (BCC)

Liens